Cargando…
Pembrolizumab-Induced Hypophysitis With Isolated Adrenocorticotropic Hormone (ACTH) Deficiency: A Rare Immune-Mediated Adverse Event
Pembrolizumab is an immune checkpoint inhibitor that targets the programmed cell death protein 1 antigen to stimulate an immune response against tumor cells. It has successfully induced remission in patients with severe metastatic disease, including those refractory to other chemotherapeutic regimen...
Autores principales: | Doodnauth, Andrew V, Klar, Miriam, Mulatu, Yohannes S, Malik, Zohra R, Patel, Krunal H, McFarlane, Samy I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186842/ https://www.ncbi.nlm.nih.gov/pubmed/34123679 http://dx.doi.org/10.7759/cureus.15465 |
Ejemplares similares
-
A Rare Cause of Cushing's Syndrome: an Adrenocorticotropic Hormone (ACTH)-Secreting Pheochromocytoma
por: Guia Lopes, Maria Leonor, et al.
Publicado: (2023) -
A Rare Presentation of Checkpoint Inhibitor Induced Distal RTA
por: Doodnauth, Andrew V., et al.
Publicado: (2021) -
Exploring a New Entity of Single-Agent Pembrolizumab-Associated Hypophysitis
por: Balti, Eric, et al.
Publicado: (2022) -
Elevated Adrenocorticotropic Hormone, Hypercortisolism, and Marked Hypernatremia
por: Wassel, Elias, et al.
Publicado: (2021) -
Isolated Adrenocorticotropic Hormone Deficiency Secondary to Chronic Opiate Use
por: Raj, Rishi, et al.
Publicado: (2020)